23.86
Amphastar Pharmaceuticals Inc Aktie (AMPH) Neueste Nachrichten
Should you wait for a breakout in Amphastar Pharmaceuticals Inc.Quarterly Portfolio Report & Safe Capital Growth Tips - newser.com
What’s next for Amphastar Pharmaceuticals Inc. stock priceEarnings Recap Report & Low Risk High Win Rate Stock Picks - newser.com
Using economic indicators to assess Amphastar Pharmaceuticals Inc. potentialAnalyst Downgrade & Precise Swing Trade Entry Alerts - newser.com
Will Amphastar Pharmaceuticals Inc. stock deliver shareholder valueWeekly Trade Review & Verified Short-Term Plans - newser.com
Does Amphastar Pharmaceuticals Inc. stock trade at a discount to peersQuarterly Market Summary & Free Risk Controlled Daily Trade Plans - newser.com
Can Amphastar Pharmaceuticals (AMPH) Navigate Heightened Trade Tensions to Protect Its Supply Chain Advantage? - Sahm
What drives Amphastar Pharmaceuticals Inc 29A stock priceTrading Volume Trends & Free Short-Term Trading Strategies - earlytimes.in
Align Technology, Envista, Centene, Amphastar Pharmaceuticals, and Oscar Health Shares Plummet, What You Need To Know - TradingView
Will Amphastar Pharmaceuticals Inc. (29A) stock gain from lower interest ratesJuly 2025 Setups & Entry and Exit Point Strategies - newser.com
BofA Cuts Price Target on Amphastar Pharmaceuticals to $31 From $32 - MarketScreener
Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs - Benzinga
Can Amphastar Pharmaceuticals Inc. stock attract ESG capital inflowsMarket Volume Report & Daily Entry Point Trade Alerts - newser.com
How to monitor Amphastar Pharmaceuticals Inc. with trend dashboardsQuarterly Risk Review & Safe Capital Growth Trade Ideas - newser.com
Will Amphastar Pharmaceuticals Inc. stock recover after recent dropMarket Volume Summary & Expert Curated Trade Setups - newser.com
Amphastar Pharmaceuticals' (AMPH) Hold (C-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Will Amphastar Pharmaceuticals Inc. (29A) stock return to pre crash levels2025 Volume Leaders & Growth Focused Entry Reports - newser.com
What analysts say about Cochlear Limited OC5 stockIPO Market Watch & Zero-Cost Stock Research by Professionals - earlytimes.in
Momentum divergence signals in Amphastar Pharmaceuticals Inc. chartAnalyst Downgrade & Precise Swing Trade Entry Alerts - newser.com
Why Amphastar Pharmaceuticals Inc. stock is a value investor pickJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference - 富途牛牛
Will Amphastar Pharmaceuticals Inc. (29A) stock beat international competitionEarnings Recap Report & Free High Return Stock Watch Alerts - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock cheap vs fundamentalsEarnings Trend Report & Expert Approved Momentum Ideas - newser.com
Amphastar Pharmaceuticals (NASDAQ:AMPH) Director Sells 500 Shares - MarketBeat
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 21.35% Potential Upside - DirectorsTalk Interviews
What analysts say about Amphastar Pharmaceuticals Inc stockPrice Momentum Alerts & Small Entry Cost Portfolio - earlytimes.in
What analysts say about Amphastar Pharmaceuticals Inc 29A stockMarket Sentiment Extremes & Breakout Stock Alerts - Early Times
What drives Amphastar Pharmaceuticals Inc stock priceValue Traps to Avoid & Outstanding Return Stocks - earlytimes.in
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):